317 related articles for article (PubMed ID: 27330189)
1. MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.
Cataisson C; Michalowski AM; Shibuya K; Ryscavage A; Klosterman M; Wright L; Dubois W; Liu F; Zhuang A; Rodrigues KB; Hoover S; Dwyer J; Simpson MR; Merlino G; Yuspa SH
Sci Signal; 2016 Jun; 9(433):ra62. PubMed ID: 27330189
[TBL] [Abstract][Full Text] [Related]
2. Science Signaling Podcast for 21 June 2016: MET and skin cancer.
Yuspa SH; VanHook AM
Sci Signal; 2016 Jun; 9(433):c14. PubMed ID: 27330186
[TBL] [Abstract][Full Text] [Related]
3. Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes.
Kelley MB; Geddes TJ; Ochiai M; Lampl NM; Kothmann WW; Fierstein SR; Kent V; DeCicco-Skinner K
PLoS One; 2022; 17(3):e0266017. PubMed ID: 35325006
[TBL] [Abstract][Full Text] [Related]
4. Modeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer.
Wright LN; Ryscavage A; Merlino G; Yuspa SH
Clin Cancer Res; 2012 Jan; 18(1):170-83. PubMed ID: 22068661
[TBL] [Abstract][Full Text] [Related]
5. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
7. Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.
Cataisson C; Ohman R; Patel G; Pearson A; Tsien M; Jay S; Wright L; Hennings H; Yuspa SH
Cancer Res; 2009 Jan; 69(1):319-28. PubMed ID: 19118017
[TBL] [Abstract][Full Text] [Related]
8. CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.
Ichise T; Yoshida N; Ichise H
J Pathol; 2019 Sep; 249(1):39-51. PubMed ID: 30953353
[TBL] [Abstract][Full Text] [Related]
9. A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans.
Mandinova A; Kolev V; Neel V; Hu B; Stonely W; Lieb J; Wu X; Colli C; Han R; Pazin MJ; Ostano P; Dummer R; Brissette JL; Dotto GP
J Clin Invest; 2009 Oct; 119(10):3127-37. PubMed ID: 19729838
[TBL] [Abstract][Full Text] [Related]
10. Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1.
Hwang MK; Bode AM; Byun S; Song NR; Lee HJ; Lee KW; Dong Z
Cancer Res; 2010 Sep; 70(17):6859-69. PubMed ID: 20660715
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
12. Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
Bajpai D; Mehdizadeh S; Uchiyama A; Inoue Y; Sawaya A; Overmiller A; Brooks SR; Hasneen K; Kellett M; Palazzo E; Motegi SI; Yuspa SH; Cataisson C; Morasso MI
Oncogene; 2021 May; 40(21):3680-3694. PubMed ID: 33947961
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the epidermal growth factor receptor and transforming growth factor-alpha during multistage skin carcinogenesis in SENCAR mice.
Rho O; Beltrán LM; Gimenez-Conti IB; DiGiovanni J
Mol Carcinog; 1994 Sep; 11(1):19-28. PubMed ID: 7916986
[TBL] [Abstract][Full Text] [Related]
14. Tumor immune escape by the loss of homeostatic chemokine expression.
Pivarcsi A; Müller A; Hippe A; Rieker J; van Lierop A; Steinhoff M; Seeliger S; Kubitza R; Pippirs U; Meller S; Gerber PA; Liersch R; Buenemann E; Sonkoly E; Wiesner U; Hoffmann TK; Schneider L; Piekorz R; Enderlein E; Reifenberger J; Rohr UP; Haas R; Boukamp P; Haase I; Nürnberg B; Ruzicka T; Zlotnik A; Homey B
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19055-60. PubMed ID: 18025475
[TBL] [Abstract][Full Text] [Related]
15. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression.
Darwiche N; Scita G; Jones C; Rutberg S; Greenwald E; Tennenbaum T; Collins SJ; De Luca LM; Yuspa SH
Cancer Res; 1996 Nov; 56(21):4942-9. PubMed ID: 8895748
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.
Abounader R; Ranganathan S; Kim BY; Nichols C; Laterra J
J Neurochem; 2001 Mar; 76(5):1497-508. PubMed ID: 11238734
[TBL] [Abstract][Full Text] [Related]
17. c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase.
Szabo R; Rasmussen AL; Moyer AB; Kosa P; Schafer JM; Molinolo AA; Gutkind JS; Bugge TH
Oncogene; 2011 Apr; 30(17):2003-16. PubMed ID: 21217780
[TBL] [Abstract][Full Text] [Related]
18. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.
Zhang Y; Xia M; Jin K; Wang S; Wei H; Fan C; Wu Y; Li X; Li X; Li G; Zeng Z; Xiong W
Mol Cancer; 2018 Feb; 17(1):45. PubMed ID: 29455668
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
20. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
